Citation: Mj. Flanigan et al., Nutritional markers during peritoneal dialysis: Data from the 1998 peritoneal dialysis core indicators study, PERIT DIA I, 21(4), 2001, pp. 345-354
Citation: Mv. Rocco et al., Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level, AM J KIDNEY, 38(4), 2001, pp. 813-823
Citation: Wm. Mcclellan et al., Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 end-stagerenal disease core indicators project, AM J KIDNEY, 37(5), 2001, pp. NIL_23-NIL_30
Citation: P. Daeihagh et Mv. Rocco, Tissue plasminogen activator use in maintaining patency in hemodialysis access catheters - Reply, AM J KIDNEY, 37(2), 2001, pp. 454-454
Authors:
Rocco, MV
Yan, GF
Heyka, RJ
Benz, R
Cheung, AK
Citation: Mv. Rocco et al., Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO Study, AM J NEPHR, 21(4), 2001, pp. 280-288
Citation: Mv. Rocco et al., Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: Results from the 1997 ESRD Core Indicators project, PERIT DIA I, 20(3), 2000, pp. 328-335
Citation: Dl. Frankenfield et al., Impact of facility size and profit status on intermediate outcomes in chronic dialysis patients, AM J KIDNEY, 36(2), 2000, pp. 318-326
Authors:
Frankenfield, D
Johnson, CA
Wish, JB
Rocco, MV
Madore, F
Owen, WF
Citation: D. Frankenfield et al., Anemia management of adult hemodialysis patients in the US: Results from the 1997 ESRD Core Indicators Project, KIDNEY INT, 57(2), 2000, pp. 578-589
Authors:
Sevick, MA
Levine, DW
Burkart, JM
Rocco, MV
Keith, J
Cohen, SJ
Citation: Ma. Sevick et al., Measurement of continuous ambulatory peritoneal dialysis prescription adherence using a novel approach, PERIT DIA I, 19(1), 1999, pp. 23-30
Citation: Mj. Flanigan et al., 1998 core indicators study - Anemia in peritoneal dialysis: Implications for future monitoring, SEMIN DIAL, 12(3), 1999, pp. 157-161
Citation: Dl. Frankenfield et al., Racia/ethnic analysis of selected intermediate outcomes for hemodialysis patients: Results from the 1997 ESRD Core Indicators Project, AM J KIDNEY, 34(4), 1999, pp. 721-730
Authors:
Flanigan, MJ
Rocco, MV
Frankenfield, D
Bailie, G
Frederick, P
Prowant, B
Taylor, L
Citation: Mj. Flanigan et al., 1997 Peritoneal dialysis-core indicators study: Dialysis adequacy and nutritional indicators report, AM J KIDNEY, 33(6), 1999, pp. E31-E312
Authors:
Bailie, GR
Frankenfield, DL
Prowant, BF
McClellan, W
Rocco, MV
Citation: Gr. Bailie et al., Erythropoietin and iron use in peritoneal dialysis patients: Report from the 1997 HCFA end-stage renal disease Core Indicators Project, AM J KIDNEY, 33(6), 1999, pp. 1187-1189
Citation: Dl. Frankenfield et al., Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 national ESRD core indicators project, AM J KIDNEY, 33(3), 1999, pp. 584-591
Authors:
Perry, JJ
Fleming, RA
Rocco, MV
Petros, WP
Bleyer, AJ
Radford, JE
Powell, BL
Hurd, DD
Citation: Jj. Perry et al., Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease, BONE MAR TR, 23(8), 1999, pp. 839-842
Citation: Dl. Frankenfield et al., Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997, KIDNEY INT, 55(5), 1999, pp. 1998-2010
Authors:
Rocco, MV
Flanigan, MJ
Prowant, B
Frederick, P
Frankenfield, DL
Citation: Mv. Rocco et al., Cycler adequacy and prescription data in a national cohort sample: The 1997 core indicators report, KIDNEY INT, 55(5), 1999, pp. 2030-2039